Electromed (NYSE:ELMD) Upgraded to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Electromed (NYSE:ELMD) from a buy rating to a strong-buy rating in a report issued on Wednesday.

Separately, TheStreet upgraded Electromed from a c+ rating to a b- rating in a report on Wednesday, February 21st.

Electromed Stock Down 0.6 %

NYSE:ELMD opened at $14.88 on Wednesday. The stock’s fifty day simple moving average is $14.74 and its 200-day simple moving average is $11.95. The firm has a market capitalization of $128.12 million, a P/E ratio of 33.07 and a beta of 0.43. Electromed has a 12-month low of $8.80 and a 12-month high of $17.85.

Electromed (NYSE:ELMD) last posted its earnings results on Tuesday, February 13th. The company reported $0.19 earnings per share for the quarter. The firm had revenue of $13.69 million for the quarter. Electromed had a return on equity of 10.32% and a net margin of 7.62%.

Institutional Trading of Electromed

A number of institutional investors have recently modified their holdings of the company. Royal Bank of Canada lifted its holdings in shares of Electromed by 1.0% in the third quarter. Royal Bank of Canada now owns 100,586 shares of the company’s stock valued at $1,031,000 after purchasing an additional 1,030 shares in the last quarter. State Street Corp lifted its holdings in shares of Electromed by 8.3% in the second quarter. State Street Corp now owns 15,736 shares of the company’s stock valued at $152,000 after purchasing an additional 1,207 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Electromed by 4.7% in the second quarter. Northern Trust Corp now owns 29,078 shares of the company’s stock valued at $311,000 after purchasing an additional 1,306 shares in the last quarter. Punch & Associates Investment Management Inc. lifted its holdings in shares of Electromed by 0.3% in the third quarter. Punch & Associates Investment Management Inc. now owns 418,896 shares of the company’s stock valued at $4,352,000 after purchasing an additional 1,431 shares in the last quarter. Finally, BlackRock Inc. lifted its holdings in shares of Electromed by 7.6% in the second quarter. BlackRock Inc. now owns 20,521 shares of the company’s stock valued at $220,000 after purchasing an additional 1,452 shares in the last quarter. 40.82% of the stock is currently owned by institutional investors.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.